The National Institute on Drug Abuse (NIDA) is offering this R01 grant to investigate whether reductions in illicit drug use are associated with improved health outcomes. This grant seeks applications for prospective and retrospective studies to identify and characterize beneficial health outcomes linked to decreased drug use. Research may include developing or validating methods and tools, such as biomarkers, to monitor these salutary consequences. The findings will stimulate translational research by providing additional health effect measures related to drug abuse and aid in evaluating new therapies for Substance Use Disorders (SUDs). The ultimate goal is to provide evidence enabling regulatory acceptance of reductions in illicit drug use as a valid outcome measure in clinical trials for SUD pharmacotherapies.
Opportunity ID: 170294
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DA-13-007 |
Funding Opportunity Title: | Identifying Health Outcomes Associated with Changes in Use of Illicit Drugs (R01) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | May 11, 2012 |
Last Updated Date: | – |
Original Closing Date for Applications: | Aug 22, 2012 |
Current Closing Date for Applications: | Aug 22, 2012 |
Archive Date: | Sep 22, 2012 |
Estimated Total Program Funding: | $3,000,000 |
Award Ceiling: | $500,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Special district governments County governments Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities City or township governments Independent school districts State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal governments (Federally recognized) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The National Institute on Drug Abuse (NIDA) is soliciting grant (R01) applications to test the hypothesis that reductions in illicit drug use are associated with improved health outcomes in patients. This FOA will support both prospective and retrospective studies, which may include, but not limited to, identification and characterization of beneficial health outcomes that are associated with reduced levels of drug use. Such studies may focus on identification and or validation of strategies, methods, and tools (including biomarkers) that can assess the salutary consequences resulting from reduced use of a particular illicit drug. These objectives may be achieved either by developing new or validating currently available methodologies that will monitor a health outcome associated with changes in use of a particular illicit drug. Further, identifying health outcomes associated with changes in drug use will stimulate translational research by providing additional measures of health effects linked to drug abuse, and may also be useful in evaluating the efficacy of new therapeutic agents for treating substance use disorders (SUDs). The ultimate goal of this FOA is to provide evidence that will enable regulatory authorities to accept reductions in illicit drug use as a valid outcome measure in clinical trials of pharmacotherapies for the treatment of SUDs. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-13-007.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
93.279 | ADOBE-FORMS-B2 | ADOBE-FORMS-B2 | PKG00121430 | Jul 22, 2012 | Aug 22, 2012 | View |
Package 1
Mandatory forms
170294 RR_SF424_1_2-1.2.pdf
170294 PerformanceSite_1_4-1.4.pdf
170294 RR_OtherProjectInfo_1_3-1.3.pdf
170294 RR_KeyPersonExpanded_1_2-1.2.pdf
170294 PHS398_CoverPageSupplement_1_4-1.4.pdf
170294 PHS398_ResearchPlan_1_3-1.3.pdf
170294 PHS398_Checklist_1_3-1.3.pdf
Optional forms
170294 RR_SubawardBudget30-1.2.pdf
170294 PHS398_ModularBudget_1_2-1.2.pdf
170294 RR_Budget-1.1.pdf
170294 PHS_CoverLetter_1_2-1.2.pdf